Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2038 of 6351
-
Blood cancer drug ASTX727 gets extended trial for ongoing patients
Disease control By invitation onlyExtension study to provide ongoing long-term treatment with ASTX727 for participants who were benefitting from ASTX727 treatment in a previous Taiho (formerly Astex)-sponsored clinical study of ASTX727 (including, but not limited to ASTX727-01 \[NCT02103478\], ASTX727-02 \[NCT033…
Phase 2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New CAR-T therapy shows promise for lymphoma patients who relapsed after prior treatment
Disease control CompletedThis is a single-center, non-randomized and dose-escalation study to evaluate the safety and efficacy of C-CAR066 in treatment of r/r DLBCL who received CD19 CAR-T therapy.
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hormone pill cuts hot flashes in half for menopausal women
Symptom relief CompletedA two-part study designed to evaluate the effect of Estetrol (E4) 15 mg, 20 mg, or placebo on the severity and frequency of vasomotor symptoms (VMS) in the Efficacy Study Part and the safety of E4 20 mg in the Safety Study Part.
Phase 3 • Sponsor: Estetra • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Experimental drug plus radiation shows promise for recurrent gynecologic cancers
Disease control Recruiting nowThis phase I trial studies the side effects and best dose of talazoparib in combination with radiation therapy and to see how well they work in treating patients with gynecologic cancers that have come back after previous treatment (recurrent). Talazoparib may stop the growth of …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a sleep medication curb nicotine cravings?
Symptom relief OngoingTobacco smoking continues to be the primary cause of preventable mortality in the United States. Despite the availability of smoking cessation aids, the majority of those trying to quit smoking end up relapsing. Thus, there is a strong need to evaluate alternative treatment targe…
Phase 1 • Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Brain boot camp: can a memory-training program sharpen thinking in multiple sclerosis?
Symptom relief CompletedThe purpose of this research study is to investigate the effectiveness of a memory enhancement technique in persons with Multiple Sclerosis.
Sponsor: Kessler Foundation • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Could migraine meds silence tinnitus? new trial investigates
Symptom relief CompletedTinnitus represents one of the most common and distressing otologic problems, and it causes various somatic and psychological disorders that interfere with the quality of life. In addition, it contributes significant costs to the healthcare system. However, the mechanisms of tinn…
Phase 4 • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Can early oxygen therapy prevent breathing failure after chest trauma?
Prevention CompletedIn blunt chest trauma patients without immediate life-threatening conditions, delayed respiratory failure and need for mechanical ventilation may still occur in 12 to 40% of patients, depending on the severity of the trauma, the preexisting conditions and the intensity of initial…
Sponsor: University Hospital, Bordeaux • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Laser eye surgery may offer a One-Time fix for reading glasses — a trial puts it to the test
Symptom relief CompletedThis study will be a 12-month, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation conducted at 8 to 14 sites. A total of 383 subjects will be enrolled to achieve approximately 268 treated subjects, resulting in at least 241 evaluable subj…
Sponsor: AMO Development, LLC • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Robots vs. scalpels: can High-Tech hernia repair get you home sooner?
Disease control Recruiting nowEvaluate the early postoperative course of patients undergoing laparoscopic inguinal hernia repair with either a conventional or a robot assisted approach and with or without the injection of the trocar wounds with a local anesthetic.
Sponsor: Algemeen Ziekenhuis Maria Middelares • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New MS drug shows promise in Long-Term safety trial
Disease control CompletedPrimary Objective: To determine the long-term safety and tolerability of SAR442168 in RMS participants Secondary Objective: To evaluate efficacy of SAR442168 on disease activity, assessed by clinical and imaging methods
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug aramchol aims to reverse fatty liver damage in phase 3 trial
Disease control PausedAn Open-Label Part was added: This part will enroll in selected sites which are less affected by the COVID-19 pandemic. 150 subjects with NASH and fibrosis confirmed by liver histology (F1-F3) will be randomized into 3 groups according to the post-baseline biopsy. The objectiv…
Phase 3 • Sponsor: Galmed Research and Development, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Mail-in HPV test could save lives of women skipping pap smears
Diagnosis Recruiting nowThe trial will evaluate whether self-sampling and human papillomavirus (HPV) testing may increase cervical cancer screening attendance among under-screened women in Czech Republic. Different ways of offering self-sampling device will be evaluated.
Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
New drug cocktail aims to boost lung cancer treatment
Disease control OngoingThis is a Phase I/Ib study whose purpose is to find out if combining an experimental drug called binimetinib with pembrolizumab is beneficial in people who have advanced non-small cell lung cancer. This study may also see if the combination is safe and may also find the best dose…
Phase 1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Laser surgery before radiation may ease urinary troubles in prostate cancer patients
Symptom relief Recruiting nowTo determine if holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms (LUTS) and/or urinary retention alters the treatment course for patients concurrently diagnosed with prostate cancer.
Sponsor: University of Kansas Medical Center • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Glue for nerves? polymer technique aims to speed up recovery after injury
Disease control CompletedCurrent strategies for peripheral nerve repair are severely limited. Even with current techniques, it can take months for regenerating axons to reach denervated target tissues when injuries are proximally located. This inability to rapidly restore the loss of function after axona…
Phase 1 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental drug combo shows promise for Tough-to-Treat gynecologic cancers
Disease control OngoingThis phase I trial studies the side effects and best dose of triapine when given with radiation therapy and cisplatin in treating patients with stage IB2-IVA cervical or vaginal cancer. Triapine may stop the growth of cancer cells by blocking an enzyme needed for cell growth. Cis…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New schizophrenia drug shows promise in major trial
Disease control CompletedA clinical trial to study the efficacy and safety of an investigational drug in acutely psychotic people with schizophrenia. Participants in the study will either receive the drug being studied or a placebo. This study is accepting male and female participants between 13 years ol…
Phase 3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New antibody combo tested against hard-to-treat cancers
Disease control OngoingThe goal of this trial is to learn about the antibody GEN1042 when it is used alone and when it is used together with another antibody cancer drug, pembrolizumab (with or without chemotherapy), for treatment of participants with certain types of cancer.
Phase 1/2 • Sponsor: Genmab • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Needles or kneading? study tests acupuncture vs. massage for advanced cancer pain
Symptom relief OngoingThe purpose of this study is to compare the long-term effectiveness of acupuncture versus massage in people living with advanced cancer. The study will test how the two approaches compare in helping people with pain and its related symptoms and improving quality of life.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC